Midsona operates in the health and wellness industry and focuses on the manufacture and distribution of dietary supplements and health products. The company's products are aimed at individuals and retailers looking for healthy alternatives. The business is global with a primary presence in Europe. Midsona was founded in 1892 and is headquartered in the city of Malmö, Sweden.
* Q2e: 1% organic growth and 4% EBITA margin * Limited estimate changes * Trading at NTM EV/EBITA of 10x Q2e: back to growth We anticipate organic growth of 1% in Q2'26e, implying sales of SEK 885m and EBIT of SEK 33m, for a margin of 3.8%. The organic...
* Health food sales need a healthier consumer climate * Margins prioritised over volume in a downside scenario * Both mix and volume needed to reach 8% margin target Moving down in Maslow's Hierarchy of Needs Today, we welcomed Midsona's new CEO, Henrik...
* Muted sales more than offset by margin expansion * Limited estimate changes on market uncertainties * Trading at NTM EV/EBITA of 8x Strong margins made up for soft sales Q1 was slightly below expectations on sales, but materially stronger than expected...
* Adj. EBIT well above estimates at SEK 45m * Underlying performance strong, but keep an eye out for ME conflict * Consensus adj. EBIT revisions likely up low-single-digits A beat where it matters The Q1 report was slightly softer than expected on sales...
* Q1e: flat organic growth and minor margin improvements * Risenta acquisition adds 3.5% to FY sales * Trading at '26e EV/EBITA of ~9.5x We expect a fairly uneventful Q1 We anticipate flat organic growth y-o-y in Q1'26e, implying sales of SEK 909m and...
* Underlying performance indicative of a brighter '26e * '26e-'27e adj. EBITA up 5% * Trading at NTM EV/EBITA of 8x Solid underlying performance boosted by NRIs Q4 came in above expectations on all key items, but was especially strong on adj. EBIT (29...
